Mary Van Doren
Mary Van Doren, Executive Editorial Director at Dark Intelligence Group partner Mequoda Group, serves as DIG’s online editor. She optimizes DIG content for the Internet to ensure that it reaches the widest possible audience.
Mary’s experience includes writing search-optimized marketing copy both for Mequoda and for Mequoda clients, including the The Dark Intelligence Group, and directly tutoring clients in SEO content marketing. She has more than three decades of experience in both marketing and journalism. Just prior to joining Mequoda Group in 2012, she spent five years as Chief Copywriter for Elsevier Business Intelligence, where she helped promote publications, databases and conferences for C-suite executives in biopharma, medical devices and diagnostics.
Articles by Mary Van Doren
Score for Theranos after AACC: Fail.
From the Volume XXIII No. 11 – August 15, 2016 Issue
This is an excerpt from a 1,600-word article in the August 15 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group. …
New Threat To Community Lab Survival: CMS Clinical Lab Fee Schedule Cuts
From the Volume XXIII No. 9 – July 5, 2016 Issue
This is an excerpt from a 2,000-word article in the July 5 issue of THE DARK REPORT. The original article is available to paid members of the Dark Intelligence Group. CEO SUMMARY: Everyone has read the basic facts, but THE DARK REPORT has gone further …
Up to 30,000 Theranos test results voided; Walgreen dumps partnership
From the Volume XXIII No. 8 – June 13, 2016 Issue
This is an excerpt from a 1,000-word article in the June 13 issue of THE DARK REPORT. The original article is available to paid members of the Dark Intelligence Group. …
AACC reveals details of its invitation to Theranos CEO
From the Volume XXIII No. 7 – May 23, 2016 Issue
This is an excerpt from a 925-word article in the May 23 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group. …
Theranos Saga Just Keeps Getting More Intriguing
From the Volume XXIII No. 6 – May 2, 2016 Issue
This is an excerpt from a 400-word article in the May 2 issue of THE DARK REPORT. The complete article is available paid members of the Dark Intelligence Group. …
CMS Update Plans for Medicare Clinical Lab Fee Schedule Could Be in Trouble
From the Volume XXIII No. 5 – April 11, 2016 Issue
This is an excerpt from a 1,400-word article in the April 11 issue of THE DARK REPORT. Full details of the California program are included in the original article, available to paid members. CEO SUMMARY: Evidence from California shows that national la…
At FDA, Laboratory-Developed Tests Are in the Crosshairs
From the Volume XXIII No. 4 – March 21, 2016 Issue
This article is an excerpt from a 600-word article in the March 21 issue of THE DARK REPORT. Full details of FDA’s laboratory-developed test guidance and recent actions against labs that are marketing LDTs are included in the original article, available to paid m…
Henry Ford Health System Labs Show How Lean Methodology in Healthcare Increases Revenues
From the Volume XXIII No. 3 – February 29, 2016 Issue
EXECUTIVE SUMMARY: Here’s a major accomplishment by the lab division of a nationally-recognized health system that has gone unreported until this DARK REPORT intelligence briefing. This article explains how using the quality management system of ISO 15189 and the Lean methodology in …
Florida bill to restrict BeaconLBS advances in state Senate
From the Volume XXIII, No. 2 – February 8, 2016 Issue
THE DARK REPORT is first to report on the latest development as part of its ongoing coverage of how Florida physicians are reacting to the implementation of the UnitedHealthCare laboratory be…
Direct Access Testing Wars Are Heating Up
From the Volume XXIII, No. 1 – January 19, 2016 Issue
CEO SUMMARY: In Phoenix, where Theranos already operates patient service centers in about 40 Walgreens pharmacies, Sonora Quest Diagnostics has an agreement with Safeway to provide clinical laboratory testing service…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized